Literature DB >> 25448239

Risk factors for leprosy reactions in three endemic countries.

David M Scollard1, Celina M T Martelli2, Mariane M A Stefani2, Maria de Fatima Maroja2, Laarni Villahermosa2, Fe Pardillo2, Krishna B Tamang2.   

Abstract

The objective of this study was to ascertain risk factors for complications (reactions or neuritis) in leprosy patients at the time of diagnosis in three leprosy-endemic countries. Newly diagnosed patients were enrolled in Brazil, the Philippines, and Nepal, and risk factors for reactions and neuritis were assessed using a case-control approach: "cases" were patients with these complications, and controls were patients without complications. Of 1,972 patients enrolled in this study, 22% had complications before treatment. Type 1 reaction was diagnosed in 13.7% of patients, neuritis alone in 6.9.%, and type 2 reaction in 1.4%. The frequency of these complications was higher in Nepal, in lepromatous patients, in males, and in adults versus children. Reactions and neuritis were seen in patients at diagnosis, before treatment was started. Reactions were seen in adults and children, even in patients with only a single lesion. Neuritis was often present without other signs of reaction. Reactions and neuritis were more likely to occur in lepromatous patients, and were more likely to be seen in adults than in children. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2014        PMID: 25448239      PMCID: PMC4347363          DOI: 10.4269/ajtmh.13-0221

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

Review 1.  Pregnancy and leprosy: a comprehensive literature review.

Authors:  D N Lockwood; H H Sinha
Journal:  Int J Lepr Other Mycobact Dis       Date:  1999-03

2.  Report of workshop on nerve damage and reactions.

Authors:  D Lockwood; D M Scollard
Journal:  Int J Lepr Other Mycobact Dis       Date:  1998-12

3.  The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome.

Authors:  P Saunderson; S Gebre; K Desta; P Byass; D N Lockwood
Journal:  Lepr Rev       Date:  2000-09       Impact factor: 0.537

4.  Reversal reactions in the skin lesions of AMFES patients: incidence and risk factors.

Authors:  P Saunderson; S Gebre; P Byass
Journal:  Lepr Rev       Date:  2000-09       Impact factor: 0.537

5.  Evaluation of male gonadal function in leprosy.

Authors:  R J Dash; E Samuel; S Kaur; B N Datta; G K Rastogi
Journal:  Horm Metab Res       Date:  1978-07       Impact factor: 2.936

6.  Age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese patients with leprosy.

Authors:  Brigitte Ranque; Van Thuc Nguyen; Hong Thai Vu; Thu Huong Nguyen; Ngoc Ba Nguyen; Xuan Khoa Pham; Erwin Schurr; Laurent Abel; Alexandre Alcaïs
Journal:  Clin Infect Dis       Date:  2006-11-28       Impact factor: 9.079

7.  The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.

Authors:  Wim H van Brakel; Peter G Nicholls; Loretta Das; Pramila Barkataki; Sujai K Suneetha; Rupendra S Jadhav; Pranava Maddali; Diana N J Lockwood; Einar Wilder-Smith; K V Desikan
Journal:  Lepr Rev       Date:  2005-03       Impact factor: 0.537

8.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

9.  Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes.

Authors:  Bishwa R Sapkota; Murdo Macdonald; William R Berrington; E Ann Misch; Chaman Ranjit; M Ruby Siddiqui; Gilla Kaplan; Thomas R Hawn
Journal:  Hum Immunol       Date:  2010-08-01       Impact factor: 2.850

10.  Epidemiological characteristics of leprosy reactions: 15 years experience from north India.

Authors:  Bhushan Kumar; Sunil Dogra; Inderjeet Kaur
Journal:  Int J Lepr Other Mycobact Dis       Date:  2004-06
View more
  20 in total

1.  Development of Type 2, But Not Type 1, Leprosy Reactions is Associated with a Severe Reduction of Circulating and In situ Regulatory T-Cells.

Authors:  Ana Paula Vieira; Maria Ângela Bianconcini Trindade; Carla Pagliari; João Avancini; Neusa Yurico Sakai-Valente; Alberto José da Silva Duarte; Gil Benard
Journal:  Am J Trop Med Hyg       Date:  2016-02-22       Impact factor: 2.345

2.  Field-Friendly Test for Monitoring Multiple Immune Response Markers during Onset and Treatment of Exacerbated Immunity in Leprosy.

Authors:  Paul L A M Corstjens; Anouk van Hooij; Elisa M Tjon Kon Fat; Susan J F van den Eeden; Louis Wilson; Annemieke Geluk
Journal:  Clin Vaccine Immunol       Date:  2016-06-06

3.  The Burden of Helminth Coinfections and Micronutrient Deficiencies in Patients with and without Leprosy Reactions: A Pilot Study in Minas Gerais, Brazil.

Authors:  Jessica K Fairley; Jose A Ferreira; Ana Laura Grossi de Oliveira; Thelma de Filippis; Maria Aparecida de Faria Grossi; Laura Pinheiro Chaves; Luiza Navarro Caldeira; Paola Souza Dos Santos; Rafaella Rodrigues Costa; Maria Cavallieri Diniz; Carolina Soares Duarte; Luiz Alberto Bomjardim Pôrto; Parminder S Suchdev; Deborah Aparecida Negrão-Corrêa; Fernanda do Carmo Magalhães; João Marcelo Peixoto Moreira; Adelino de Melo Freire Júnior; Mariana Costa Cerqueira; Uriel Kitron; Sandra Lyon
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

4.  Serum uric acid levels during leprosy reaction episodes.

Authors:  Yvelise T Morato-Conceicao; Eduardo R Alves-Junior; Talita A Arruda; Jose C Lopes; Cor J F Fontes
Journal:  PeerJ       Date:  2016-03-14       Impact factor: 2.984

5.  The involvement of endothelial mediators in leprosy.

Authors:  Maria Renata Sales Nogueira; Ana Carla Pereira Latini; Maria Esther Salles Nogueira
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-10-03       Impact factor: 2.743

6.  Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases.

Authors:  Mariane M A Stefani; Charlotte Avanzi; Samira Bührer-Sékula; Andrej Benjak; Chloé Loiseau; Pushpendra Singh; Maria A A Pontes; Heitor S Gonçalves; Emerith M Hungria; Philippe Busso; Jérémie Piton; Maria I S Silveira; Rossilene Cruz; Antônio Schetinni; Maurício B Costa; Marcos C L Virmond; Suzana M Diorio; Ida M F Dias-Baptista; Patricia S Rosa; Masanori Matsuoka; Maria L F Penna; Stewart T Cole; Gerson O Penna
Journal:  PLoS Negl Trop Dis       Date:  2017-06-15

7.  Leprosy Reaction in Thai Population: A 20-Year Retrospective Study.

Authors:  Poonkiat Suchonwanit; Siripich Triamchaisri; Sanchawan Wittayakornrerk; Ploysyne Rattanakaemakorn
Journal:  Dermatol Res Pract       Date:  2015-10-05

8.  A Missense LRRK2 Variant Is a Risk Factor for Excessive Inflammatory Responses in Leprosy.

Authors:  Vinicius M Fava; Jérémy Manry; Aurélie Cobat; Marianna Orlova; Nguyen Van Thuc; Nguyen Ngoc Ba; Vu Hong Thai; Laurent Abel; Alexandre Alcaïs; Erwin Schurr
Journal:  PLoS Negl Trop Dis       Date:  2016-02-04

Review 9.  Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome.

Authors:  Zachary A Klase; Svetlana Khakhina; Adriano De Bernardi Schneider; Michael V Callahan; Jill Glasspool-Malone; Robert Malone
Journal:  PLoS Negl Trop Dis       Date:  2016-08-25

10.  Identifying Leprosy and Those at Risk of Developing Leprosy by Detection of Antibodies against LID-1 and LID-NDO.

Authors:  Francianne M Amorim; Maurício L Nobre; Leonardo C Ferreira; Larissa S Nascimento; Alesson M Miranda; Glória R G Monteiro; Kathryn M Dupnik; Malcolm S Duthie; Steven G Reed; Selma M B Jeronimo
Journal:  PLoS Negl Trop Dis       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.